Current Pharmacogenomics and Personalized Medicine

Current Pharmacogenomics and Personalized Medicine

Editor-in-Chief

ISSN (Print): 1875-6921
ISSN (Online): 1875-6913

Back Subscribe
Review Article

Tracking the Evolution of Artificial Intelligence in Pharmacogenomics: A Bibliometric Approach to Personalized Healthcare

Author(s): Hemasri Velmurugan*orcid of author and Tamilarasan Murugesanauthors OrcID

Volume 23, 2026

Published on: 23 October, 2025

Article ID: e18756921407724

Pages: 11

DOI: 10.2174/0118756921407724251015113115

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

The application of artificial intelligence (AI) techniques like machine learning (ML) and deep learning (DL) has gained significant momentum in pharmacogenomics (PGx). AI models can identify promising drug candidates likely to interact with particular genetic profiles. The research works and bibliographic details regarding the use of artificial intelligence in pharmacogenomics were obtained from PubMed between 1st January 2004 and 1st April 2025. The relative growth rate (RGR) analysis shows a decline in recent years, but the increasing doubling time might reflect the complex nature of research in this field. Out of 282 publications, most articles were published in 2024, reflecting the growing adoption of AI tools within this area. Multiple researchers authored many studies. India ranks fifth, contributing 11 (3.9%) articles. The findings underscore the swift expansion, collaborative efforts, and international scope of research in AI-driven pharmacogenomics.

Keywords: Bibliometric, scientometric, pharmacogenomics, artificial intelligence, machine learning (ML), deep learning (DL).


Rights & Permissions Print Cite